Atnaujinkite slapukų nuostatas

El. knyga: Addiction and the Making of Professional Careers

  • Formatas: 344 pages
  • Išleidimo metai: 08-Sep-2017
  • Leidėjas: Routledge
  • Kalba: eng
  • ISBN-13: 9781351533973
Kitos knygos pagal šią temą:
Addiction and the Making of Professional CareersDidesnis paveikslėlis
  • Formatas: 344 pages
  • Išleidimo metai: 08-Sep-2017
  • Leidėjas: Routledge
  • Kalba: eng
  • ISBN-13: 9781351533973
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

This collection of thirty interviews from ten countries considers aspects of careers related to addiction, ranging from medical intervention to research and therapeutic endeavors. The book explores how individuals make the choice to enter the field, how best to select and support those wanting to begin this work, and how talent can be nurtured and applied to the most effect. Sections are divided by field and include: administration, pharmacology and behavioral pharmacology, clinicians and clinical science and social science and epidemiology. Commonalities and recurring themes are addressed in each section's commentaries. Annotation ©2012 Book News, Inc., Portland, OR (booknews.com)

The misuse of drugs continues to cause suffering and worldwide economic turmoil. In response to these problems, many have devoted their lives to preventing the misuse of mind-altering substances. Addiction and the Making of Profession Careers focuses on the need for enhanced understanding of professional careers in the addiction field. The spectrum of professionals involved is wide and includes treatment personnel of every kind.

Some of the questions examined here include: Why do some people decide to dedicate their lives to responding to drug problems? How do and should we select, train, mentor, support, inspire, and nurture the young career aspirant? What makes for the most effective use of talent? Is every personal case different or can general conclusions be reached?

After a foreword by William Miller and an introduction by Griffith Edwards, the book includes interviews with Joseph Brady, Louis Harris, Conan Kornetsky, and Robert DuPont, all of whom were pioneers in the behavioral pharmacological analysis of addiction. Commentary chapters are written by Kerstin Stenius, Ilana Crome, Peter Anderson, and Jonathan Chick.

Foreword xi
William R. Miller
Acknowledgments xiii
Introduction: Careers Set Questions 1(9)
Griffith Edwards
Part 1 Addiction Careers and Administration at a High Level
1 Conversation with Robert L. DuPont, MD., President of the Institute for Behavior and Health, Inc. Rockville, MD, USA and Clinical Professor of Psychiatry, Georgetown University School of Medicine, Washington, DC, USA
10(6)
Barry Brown
2 Conversation with Richard Fuller, MD, Retired
16(7)
Raymond Anton
3 Conversation with Cees Goos, MD., Consultant, Anton Proksch Institute, Vienna, Austria
23(7)
Paul Lemmens
4 Conversation with Enoch Gordis, MD., Retired
30(7)
Stephanie O'Malley
5 Conversation with Leland H. Towle, SM (MIT), Retired
37(7)
Thomas Babor
6 Commentary by Peter Anderson, MD, PhD, MPH., Professor, Alcohol and Health, Faculty of Health Medicine and Life Sciences, Maastricht, Netherlands
44(8)
Part 2 Laboratory Life: The Making of Addiction Pharmacology and Behavioural Pharmacology
7 Conversation with Joseph V. Brady, PhD., Formerly Director, Behavioral Biology Research Center, John Hopkins Medicine, Baltimore, MD, USA (Deceased 29 July 2011)
52(6)
Jerome H. Jaffe
8 Conversation with E. A. Carlini, MD., Professor, Federal University of Sao Paulo, Sao Paulo, Brazil
58(6)
Joao Carlos Dias da Silva
9 Conversation with Lou Harris, PhD., Harvey Haag Professor, Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond VA, USA
64(7)
William Dewey
10 Conversation with Conan Kornetsky, PhD., Professor, Departments of Psychiatry and Pharmacology, Boston University School of Medicine, Boston, Massachusetts, USA
71(8)
Jerome H. Jaffe
11 Conversation with Michael Kuhar, PhD., Chandler Professor of Neuropharmacology, Georgia Research Alliance Eminent Scholar, Yerkes/Emory University, Atlanta GA, USA
79(7)
Nancy Campbell
12 Conversation with Malcolm H. Lader, MD., PhD., FMedSci., Emeritus Professor of Clinical Psychopharmacology, Institute of Psychiatry, Kings College London, UK
86(7)
Griffith Edwards
13 Conversation with Raphael Mechoulam, PhD., Emeritus Professor, Hebrew University, Institute for Drug Research, Medical Faculty, Institute for Drug Research, Ein Kerem Campus, Jerusalem, Israel
93(7)
Ruth Gallily
14 Conversation with Charles R. Schuster, PhD, Formerly Distinguished Professor Emeritus, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine USA (Deceased 21 February 2011)
100(7)
Robert Balster
15 Conversation with Tomoji Yanagita, MD., Professor and Director of the Central Laboratory for Experimental Animals, Kawasaki, Japan
107(7)
Charles R. Schuster
16 Commentary by Jerome H. Jaffe, MD., Clinical Professor, Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, Maryland, USA
114(12)
Part 3 Clinicians and Clinical Scientists
17 Conversation with Timothy Cook, MA, Formerly Director, London and City Parochial Charities, London, UK
126(7)
Betsy Thom
18 Conversation with Hamid Ghodse, MD., PhD., BSc., Emeritus Professor of Psychiatry and International Drug Policy and Director, International Centre for Drug Policy, St George's University of London, London, UK
133(7)
Andrew Johns
19 Conversation with Nick Heather, PhD., Emeritus Professor of Alcohol and Other Drug Studies, Department of Psychology, School of Life Sciences, Northumbria University, Newcastle upon Tyne, UK
140(7)
Robert West
20 Conversation with Martin Jarvis, PhD., Emeritus Professor of Health Psychology, Department of Epidemiology & Public Health, University College London, London, UK
147(7)
Robert West
21 Conversation with Jim Orford, PhD., Emeritus Professor, School of Psychology, University of Birmingham, Edgbaston, Birmingham, UK
154(8)
Gillian Tober
22 Conversation with Shanthi Ranganathan, MD. Founder and Hon Secretary, T.T. Ranganathan Clinical Research Foundation, TTK Hospital, Chennai, India
162(6)
M.S. Jayaraman
23 Conversation with Bruce Ritson, MD, Formerly Consultant and Hon Senior Lecturer, Royal Edinburgh Hospital, UK
168(8)
Iain Smith
24 Conversation with Michael A. H. Russell, MA, MAppSci, PhD. Formerly Professor of Addiction, Institute of Psychiatry, London, UK. (Deceased 16 July 2009)
176(7)
Martin Jarvis
25 Conversation with Hiroshi Suwaki, MD., Consultant, Honorary Professor of Kagawa University, Incorporated Medical Institution, Sankou Psychiatric Hospital, Kagawa, Japan
183(8)
Griffith Edwards
26 Conversation with Ambros Uchtenhagen, MD., PhD., Emeritus Professor of Social Psychiatry at Zurich University, Chair, Addiction and Public Health Research Foundation at Zurich University, Research Institute for Public Health and Addiction, Zurich, Switzerland
191(7)
Michael Kraus
27 Commentary by Ilana Crome, MD, FRCPsych, Formerly Professor of Addiction Psychiatry and Academic Director of Psychiatry, Keele University Medical School, Consultant, Addiction Psychiatrist, South Staffordshire and Shropshire Healthcare NHS Foundation Trust, St George's Hospital, Stafford, UK
198(10)
Part 4 Careers in Social Science and Epidemiology
28 Conversation with M. Douglas Anglin, PhD., Professor in Residence, Associate Director, Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA
208(8)
Richard Rawson
29 Conversation with Walter Clark, PhD, Senior Scientist, Alcohol Research Group, Berkeley, California, USA
216(6)
Raul Caetano
30 Conversation with Joseph Gusfield, PhD., Chair of the Sociology Department, University of California, La Jolla, California, USA
222(7)
Richard Madsen
31 Conversation with Ragnar Hauge, Cand.Jur., former Director of the National Institute of Alcohol and Drug Research, Oslo, Norway
229(7)
Michael Blindheim
32 Conversation with Harold Holder, PhD, Senior Scientist Emeritus, Prevention Research Center, Pacific Institute for Research and Evaluation, El Cerrito, California, USA
236(7)
Keith Humphreys
33 Conversation with Rudolf Moos, PhD., Professor Emeritus, Department of Psychiatry, Stanford University, Palo Alto, California, USA
243(8)
John Finney
34 Conversation with Juha Partanen, PhD, Formerly Professor and Director, Social Research Institute for Alcohol Studies, Helsinki, Finland
251(7)
Robin Room
35 Commentary by Kerstin Stenius, PhD., Editor-in-Chief, Nordisk Alkohol-och Narkotikatidskrift (Nordic Studies on Alcohol and Drugs), Helsinki, Finland; Professor, Centre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, Sweden
258(8)
Part 5 Clinicians and Clinical Research: American Contributions
36 Conversation with Sheila Blume, MD., Former Medical Director, Addiction and Compulsive Gambling Services, South Oaks Hospital, Amityville, New York, USA
266(7)
Marianne Guschwan
37 Conversation with Roger E. Meyer, MD., Professor of Psychiatry, Penn State University Hershey Medical Center, Hershey, PA, USA
273(8)
Hank Kranzler
38 Conversation with William R. Miller, PhD., Emeritus Distinguished Professor of Psychology and Psychiatry, University of New Mexico, New Mexico, USA
281(6)
Barbara McCrady
39 Conversation with George Vaillant, MD., Professor of Psychiatry, Harvard Study of Adult Development, Boston, Massachusetts, USA
287(7)
Thomas F. Babor
Griffith Edwards
40 Conversation with William L. White, MA., Senior Research Consultant, Chestnut Health Systems, Lighthouse Institute, Illinois, USA
294(7)
Thomas McGovern
41 Commentary by Jonathan Chick, MA (Cantab), MPhil, DSc, FRCPE, FRCPsych., Honorary Professor, School of Health Sciences, Queen Margaret University, Edinburgh, United Kingdom
301(6)
Addiction Careers: Catalysts for an Interdisciplinary Field
42 Thomas F. Babor, PhD, MPH. Associate Editor-in-Chief, Addiction; Regional Editor for Addiction, US Office; Professor and Chairman, Department of Community Medicine & Health Care, University of Connecticut School of Medicine, Farmington, Connecticut, USA
307(12)
Index 319
Griffith Edwards
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97813515339736e.html
Raktažodžiai: